Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

Presentation Fellows 2015

Case 2

Presenter: Roxana Mehran, David J. Cohen, Kevin J. Croce

May 15, 2015

Presentation Fellows 2015

Case 1

Presenter: Roxana Mehran, David J. Cohen, Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

Advertisement

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Case 2

Case 1

Antithrombin Pharmacology for the Interventionalist

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content